Skip to main content
. 2021 Nov 30;12:755401. doi: 10.3389/fimmu.2021.755401

Figure 6.

Figure 6

The correlation between LUAD-related ISs and immune modulators and the feature of immune cells in different ISs. (A) Differentially expressed ICP genes in different LUAD ISs. (B) Differentially expressed ICD genes in different LUAD ISs. Kruskal–Wallis test with * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.001. ns presents no difference. (C) Differential enrichment scores of immune cell signatures among five ISs in TCGA cohorts. (D) Differential enrichment scores of ten prognosis-related immune cell signatures. (E) The distribution of five pan-cancer ISs in five LUAD-related ISs. (F) Differential enrichment scores of twenty-four immune signatures.